<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>3D Printing for Drugs by Meagen Smith</title>
      <link>https://padlet.com/msmith1121/xx90lhyjvgfe</link>
      <description>The future of oral tablets</description>
      <language>en-us</language>
      <pubDate>2017-10-10 01:34:48 UTC</pubDate>
      <lastBuildDate>2017-10-10 03:19:54 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>References:</title>
         <author>msmith1121</author>
         <link>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195422079</link>
         <description><![CDATA[<div>McGonigle, D., &amp; Mastrian, K.G. (2018).  <em>Nursing informatics and the foundation of knowledge.</em>  Burlington, MA:  Jones &amp; Bartlett Learning<br><br>Markarian, J. (2016). Using 3D Printing for Solid-Dosage Drugs. <em>Pharmaceutical Technology Europe</em>, <em>28</em>(8), 30-32</div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-10 01:44:56 UTC</pubDate>
         <guid>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195422079</guid>
      </item>
      <item>
         <title>Pros</title>
         <author>msmith1121</author>
         <link>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195422668</link>
         <description><![CDATA[<div>It would increase medication adherence if the patient did not have to take so many pills. <br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-10 01:49:18 UTC</pubDate>
         <guid>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195422668</guid>
      </item>
      <item>
         <title>Cons</title>
         <author>msmith1121</author>
         <link>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195422692</link>
         <description><![CDATA[<div>First and foremost cost will be a factor. As technology improves, prices increase.  <br><br>If a patient was removed from a specific medication due to dosage increase or decrease, their current supply of printed drugs would be a waste.  Therefore possibly lots of money wasted.  <br><br>I would also assume that insurances would only pay for a 30 day supply or less due to the cost and risk for changes in medications.  </div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-10 01:49:30 UTC</pubDate>
         <guid>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195422692</guid>
      </item>
      <item>
         <title>Watch this:</title>
         <author>msmith1121</author>
         <link>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195427772</link>
         <description><![CDATA[<div><a href="https://www.youtube.com/watch?v=9mHnCnX4al0">https://www.youtube.com/watch?v=9mHnCnX4al0</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-10 02:30:47 UTC</pubDate>
         <guid>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195427772</guid>
      </item>
      <item>
         <title>Summary of this innovation: </title>
         <author>msmith1121</author>
         <link>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195428900</link>
         <description><![CDATA[<div>Aprecia made the first FDA approved 3D-printed drug in August 2015. It is considered a   ZipDose tablet which is both a formulation platform and process for manufacturing. “The three primary benefits we see are the rapid disintegration in the mouth with a sip of liquid, along with taste-masking ability and high drug load. When we look across the landscape of central nervous system (CNS) drugs, we see that typically a high-drug dose is needed, often in a large pill that needs to be swallowed intact. Some patients struggle to swallow their medication, however, either due to the size of the pill or due to comorbid conditions associated with their medical issues. In this therapeutic area, we feel there is an opportunity to meet patient needs with a new dosing option (Markarian, 2016).” </div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-10 02:41:36 UTC</pubDate>
         <guid>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195428900</guid>
      </item>
      <item>
         <title>Opinion:</title>
         <author>msmith1121</author>
         <link>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195429000</link>
         <description><![CDATA[<div>I would love to see this happen. However I like in rural East Texas where there is a great deal of the population at poverty or below poverty level. With that being said I do not feel like this is anything we would see here anytime soon. However lots of patients are sent to bigger hospitals in big cities such as Dallas or Houston and I can definitely see them personalizing the drugs for patients there. I personally do not see medicaid paying for this anytime soon. With the exception of severely ill patients who may require precision with dosing.  However as scientist become more skilled and get this down and drive cost down, I may be completely wrong, it may be here in East Texas.   "As educators become more skilled in the use of the tools, and as designers share their creative works with others, we can expect to see these tools used more frequently in the coming decade" (McGonigle, &amp; Mastrian, 2018)</div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-10 02:42:25 UTC</pubDate>
         <guid>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195429000</guid>
      </item>
      <item>
         <title></title>
         <author>msmith1121</author>
         <link>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195432169</link>
         <description><![CDATA[<div><figure class="attachment attachment--preview"><img src="http://img.publishthis.com/images/3_0/2015/08/f/2/a/f2aa2d755234e26f2afe280f501e2412_feed_520x245_xlarge_thumbnail_1.jpg?W=700&amp;H=350" width="700" height="350"><figcaption class="attachment__caption"></figcaption></figure></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-10 03:06:58 UTC</pubDate>
         <guid>https://padlet.com/msmith1121/xx90lhyjvgfe/wish/195432169</guid>
      </item>
   </channel>
</rss>
